breath actuated nebulizer

DEVICE4 trials

Sponsors

Christiana Care Health Services, Duke University, Le Bonheur Children's Hospital, Dynavax Technologies Corporation

Conditions

Advanced Non Small Cell Lung CancerAsthmaChronic Obstructive Pulmonary Disease

Phase 1

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

CompletedNCT03326752

Dynavax Technologies CorporationAdvanced Non Small Cell Lung Cancer

Start: 2017-09-20End: 2019-09-19Updated: 2020-06-17

Phase 4

Aerosolized Beta-Agonist Isomers in Asthma

CompletedNCT02170532

Duke UniversityAsthma

Start: 2007-07-31End: 2009-07-31Updated: 2014-08-13

Unknown Phase

Breath Actuated Nebulizer Study Protocol

WithdrawnNCT00382447

Christiana Care Health ServicesAsthma, Chronic Obstructive Pulmonary Disease

Start: 2006-10-31End: 2008-06-30Updated: 2012-12-13

A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers

CompletedNCT02777125

Le Bonheur Children's HospitalAsthma

Start: 2014-10-31End: 2015-04-30Updated: 2017-08-15

Related Papers

Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)

Cancer Research2019-07-014 citations

Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)

Clinical Trials2019-07-012 citations